Trading resumes in Chelsea Therapeutics, up ~35% AH

Chelsea Therapeutics (CHTP) resumes trading after being halted following the FDA's approval of Northera; shares now +35.5% after trading 33%-40% higher since restarting at 5:25.

From other sites
Comments (1)
  • GreenGrowthGeek
    , contributor
    Comments (2029) | Send Message
    Glad I hung in there and didn't get cold feet. Many doubters were saying the odds were 70% or less for approval and that there would be restrictions etc... but that 16-1 committee vote had me convinced that the odds were over 90% and that beats any casino any day. If Deutsche Bank is correct, the stock should easily hit $8 with an upside to $12 unless I'm missing something.
    18 Feb 2014, 09:02 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs